Reducing hepatitis C diagnostic disparities with a fully automated deep learning–enabled microfluidic system for HCV antigen detection
Science Advances · 21.03.2025 · 11 (12)
DOI: 10.1126/sciadv.adt3803 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, erschienen am 21.03.2025. Verfasst von Hui Chen und 23 weiteren Autor:innen. Beteiligte Einrichtung: Division of Engineering in Medicine, Division of Renal Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston…. Hauptthemen laut MEDLINE: Deep Learning, Hepatitis C, Hepacivirus, Hepatitis C Antigens. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NICHD NIH HHS, NIAID NIH HHS, NHLBI NIH HHS.
Abstract (Originalsprache)
Viral hepatitis remains a major global health issue, with chronic hepatitis B (HBV) and hepatitis C (HCV) causing approximately 1 million deaths annually, primarily due to liver cancer and cirrhosis. More than 1.5 million people contract HCV each year, disproportionately affecting vulnerable populations, including American Indians and Alaska Natives (AI/AN). While direct-acting antivirals (DAAs) are highly effective, timely and accurate HCV diagnosis remains a challenge, particularly in resource-limited settings. The current two-step HCV testing process is costly and time-intensive, often leading to patient loss before treatment. Point-of-care (POC) HCV antigen (Ag) testing offers a promising alternative, but no FDA-approved test meets the required sensitivity and specificity. To address this, we developed a fully automated, smartphone-based POC HCV Ag assay using platinum nanoparticles, deep learning image processing, and microfluidics. With an overall accuracy of 94.59%, this cost-effective, portable device has the potential to reduce HCV-related health disparities, particularly among AI/AN populations, improving accessibility and equity in care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Engineering in Medicine, Division of Renal Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02139, USA.
- Liver Center, Gastrointestinal Division, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.
- Infectious Diseases, Cherokee Nation Health Services, Tahlequah, OK, 74464, USA.
ORCID-Profile: Hui Chen, Manasvi Alam, Qazi Noorul Mateen, Katherine Cilley, Sungwan Kim, Giwon Cho, Joseph Michael Hardie, Manoj Kumar Kanakasabapathy, Hemanth Kandula, Prudhvi Thirumalaraju, Younseong Song, Arafeh Bigdeli, Gregory P Fricker, Raymond T Chung, Jorge Mera, Hadi Shafiee
Förderung
- NICHD NIH HHS
- NIAID NIH HHS
- NHLBI NIH HHS
- NIBIB NIH HHS
Zitieren
APA
Chen, H., Gao, Y., Li, G., Alam, M., Udayakumar, S., Mateen, Q. N., Rostamian, S., Cilley, K., Kim, S., Cho, G., Gwak, J., Song, Y., Hardie, J. M., Kanakasabapathy, M. K., Kandula, H., Thirumalaraju, P., Song, Y., Parandakh, A., Bigdeli, A., …, & Shafiee, H. (2025). Reducing hepatitis C diagnostic disparities with a fully automated deep learning–enabled microfluidic system for HCV antigen detection. Science Advances, 11(12). https://doi.org/10.1126/sciadv.adt3803
Vancouver
Chen H, Gao Y, Li G, Alam M, Udayakumar S, Mateen QN, et al. Reducing hepatitis C diagnostic disparities with a fully automated deep learning–enabled microfluidic system for HCV antigen detection. Science Advances. 2025;11(12). doi:10.1126/sciadv.adt3803
BibTeX
@article{Chen2025,
author = {Chen, Hui and Gao, Yuxin and Li, Gaojian and Alam, Manasvi and Udayakumar, Srisruthi and Mateen, Qazi Noorul and Rostamian, Sahar and Cilley, Katherine and Kim, Sungwan and Cho, Giwon and Gwak, Juyong and Song, Yixuan and Hardie, Joseph Michael and Kanakasabapathy, Manoj Kumar and Kandula, Hemanth and Thirumalaraju, Prudhvi and Song, Younseong and Parandakh, Azim and Bigdeli, Arafeh and Fricker, Gregory P and Gustafson, Jenna and Chung, Raymond T and Mera, Jorge and Shafiee, Hadi},
title = {Reducing hepatitis C diagnostic disparities with a fully automated deep learning–enabled microfluidic system for HCV antigen detection},
journal = {Science Advances},
year = {2025},
volume = {11},
number = {12},
doi = {10.1126/sciadv.adt3803}
}
EUVIMED